{"id":"https://openalex.org/W7225577273","doi":"https://doi.org/10.5281/zenodo.24057765","title":"Autonomous Infrastructure & Deterministic Quantum Systems Monograph Series: Unified Comparative & Precision Oncology Paradigm of Evolutionary Bio-Defense Complexes (HAMLET/Alpha1H & HMO Synergy) vs. AI-Driven De Novo Protein Design (AlphaProteo): Poly-Organellar Tumor Lethality, Liquid Biopsy Transcriptomics, Immunogenicity Bottlenecks, and Deterministic Bio-Pharmaceutical Governance / \u81ea\u5f8b\u30a4\u30f3\u30d5\u30e9\u3068\u6c7a\u5b9a\u8ad6\u7684\u91cf\u5b50\u30b7\u30b9\u30c6\u30e0 \u30e2\u30ce\u30b0\u30e9\u30d5\u30b7\u30ea\u30fc\u30ba:\u6bcd\u4e73\u7531\u6765\u9032\u5316\u578b\u751f\u4f53\u9632\u5fa1\u8907\u5408\u4f53(HAMLET/Alpha1H\u30fbHMO\u76f8\u4e57\u6a5f\u69cb)\u3068AI\u99c6\u52d5\u578bDe Novo\u8a2d\u8a08\u30bf\u30f3\u30d1\u30af\u8cea(AlphaProteo)\u304a\u3088\u3073\u7cbe\u5bc6\u304c\u3093\u30b2\u30ce\u30df\u30af\u30b9\u306e\u7d71\u5408\u6cbb\u7642\u30d1\u30e9\u30c0\u30a4\u30e0:\u30dd\u30ea\u30aa\u30eb\u30ac\u30cd\u30e9\u9078\u629e\u7684\u816b\u760d\u6b7b\u6ec5\u6a5f\u69cb\u3001\u30ea\u30ad\u30c3\u30c9\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u52d5\u7684\u89e3\u6790\u3001\u514d\u75ab\u539f\u6027\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3001\u304a\u3088\u3073\u6c7a\u5b9a\u8ad6\u7684\u30d0\u30a4\u30aa\u533b\u85ac\u30ac\u30d0\u30ca\u30f3\u30b9","display_name":"Autonomous Infrastructure & Deterministic Quantum Systems Monograph Series: Unified Comparative & Precision Oncology Paradigm of Evolutionary Bio-Defense Complexes (HAMLET/Alpha1H & HMO Synergy) vs. AI-Driven De Novo Protein Design (AlphaProteo): Poly-Organellar Tumor Lethality, Liquid Biopsy Transcriptomics, Immunogenicity Bottlenecks, and Deterministic Bio-Pharmaceutical Governance / \u81ea\u5f8b\u30a4\u30f3\u30d5\u30e9\u3068\u6c7a\u5b9a\u8ad6\u7684\u91cf\u5b50\u30b7\u30b9\u30c6\u30e0 \u30e2\u30ce\u30b0\u30e9\u30d5\u30b7\u30ea\u30fc\u30ba:\u6bcd\u4e73\u7531\u6765\u9032\u5316\u578b\u751f\u4f53\u9632\u5fa1\u8907\u5408\u4f53(HAMLET/Alpha1H\u30fbHMO\u76f8\u4e57\u6a5f\u69cb)\u3068AI\u99c6\u52d5\u578bDe Novo\u8a2d\u8a08\u30bf\u30f3\u30d1\u30af\u8cea(AlphaProteo)\u304a\u3088\u3073\u7cbe\u5bc6\u304c\u3093\u30b2\u30ce\u30df\u30af\u30b9\u306e\u7d71\u5408\u6cbb\u7642\u30d1\u30e9\u30c0\u30a4\u30e0:\u30dd\u30ea\u30aa\u30eb\u30ac\u30cd\u30e9\u9078\u629e\u7684\u816b\u760d\u6b7b\u6ec5\u6a5f\u69cb\u3001\u30ea\u30ad\u30c3\u30c9\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u52d5\u7684\u89e3\u6790\u3001\u514d\u75ab\u539f\u6027\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3001\u304a\u3088\u3073\u6c7a\u5b9a\u8ad6\u7684\u30d0\u30a4\u30aa\u533b\u85ac\u30ac\u30d0\u30ca\u30f3\u30b9","publication_year":2026,"publication_date":"2026-11-08","ids":{"openalex":"https://openalex.org/W7225577273","doi":"https://doi.org/10.5281/zenodo.24057765"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24057765","doi":"https://doi.org/10.5281/zenodo.24057765","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24057765","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24057765","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5158982858","display_name":"Yoko(\u6d0b\u5b50) Hasebe(\u9577\u8c37\u90e8)","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hasebe(\u9577\u8c37\u90e8), Yoko(\u6d0b\u5b50)","raw_affiliation_strings":["Lead Researcher, Autonomous Infrastructure Systems, Autonomous Living & Physical Infrastructure Institute, Iwakuni, Yamaguchi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lead Researcher, Autonomous Infrastructure Systems, Autonomous Living & Physical Infrastructure Institute, Iwakuni, Yamaguchi, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5158982858"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.22030000388622284,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.22030000388622284,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11710000038146973,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.10209999978542328,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hamlet","display_name":"Hamlet","score":0.7770000100135803},{"id":"https://openalex.org/keywords/human-milk-oligosaccharides","display_name":"human milk oligosaccharides","score":0.9739999771118164},{"id":"https://openalex.org/keywords/de-novo-protein-design","display_name":"de novo protein design","score":0.765999972820282},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.7310000061988831},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5960000157356262},{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.7760000228881836},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5361999869346619},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4959000051021576},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45890000462532043},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.3991999924182892},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3847000002861023},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3619000017642975},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.3395000100135803},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.33009999990463257},{"id":"https://openalex.org/C2779529041","wikidata":"https://www.wikidata.org/wiki/Q22349364","display_name":"Liquid biopsy","level":3,"score":0.3224000036716461},{"id":"https://openalex.org/C145290725","wikidata":"https://www.wikidata.org/wiki/Q5533489","display_name":"Genome engineering","level":5,"score":0.3084999918937683},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3073999881744385},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.29670000076293945},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29429998993873596},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.28119999170303345},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.2705000042915344},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.26820001006126404}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24057765","doi":"https://doi.org/10.5281/zenodo.24057765","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24057765","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},{"id":"doi:10.5281/zenodo.24057766","doi":"https://doi.org/10.5281/zenodo.24057766","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24057766","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24057765","doi":"https://doi.org/10.5281/zenodo.24057765","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24057765","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Preprint"},"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7213749136","https://openalex.org/W7214579601","https://openalex.org/W7225565482","https://openalex.org/W7223207363","https://openalex.org/W7215032577","https://openalex.org/W3112543883","https://openalex.org/W2991166881","https://openalex.org/W7093639085","https://openalex.org/W2619902780","https://openalex.org/W3158692877"],"abstract_inverted_index":{"\u3010\u8981\u65e8":[0],"(Abstract":[1],"-":[2,283,285,287,289,293,295,297,302,304,308,310,312,321,332,343],"Japanese)\u3011":[3],"\u6bcd\u4e73\u306f\u65b0\u751f\u5150\u306e\u6804\u990a\u6e90\u306b\u3068\u3069\u307e\u3089\u305a\u3001\u6570\u767e\u4e07\u5e74\u306e\u9032\u5316\u5727\u3092\u901a\u3058\u3066\u7cbe\u7dfb\u5316\u3055\u308c\u305f\u591a\u69d8\u306a\u751f\u7406\u6d3b\u6027\u7269\u8cea\u3068\u751f\u4f53\u9632\u5fa1\u6a5f\u69cb\u3092\u5099\u3048\u305f\u9ad8\u5ea6\u306a\u751f\u7269\u5b66\u7684\u60c5\u5831\u4f1d\u9054\u30e1\u30c7\u30a3\u30a2\u3067\u3042\u308b\u3002\u7279\u306b\u3001\u90e8\u5206\u5909\u6027\u03b1-\u30e9\u30af\u30c8\u30a2\u30eb\u30d6\u30df\u30f3\u3068\u30aa\u30ec\u30a4\u30f3\u9178\u306e\u8907\u5408\u4f53\u3067\u3042\u308b\u300cHAMLET\u300d\u304a\u3088\u3073\u305d\u306e\u5408\u6210\u30da\u30d7\u30c1\u30c9\u8907\u5408\u4f53\u300cAlpha1H\u300d\u306f\u300140\u7a2e\u985e\u4ee5\u4e0a\u306e\u60aa\u6027\u816b\u760d\u7d30\u80de\u3092\u9078\u629e\u7684\u306b\u6b7b\u6ec5\u3055\u305b\u308b\u4e00\u65b9\u3001\u6b63\u5e38\u5206\u5316\u7d30\u80de\u306b\u306f\u50b7\u5bb3\u3092\u4e0e\u3048\u306a\u3044\u3068\u3044\u3046\u7279\u7570\u306a\u85ac\u7406\u6d3b\u6027\u3092\u793a\u3059\u3002\u307e\u305f\u3001\u30d2\u30c8\u30df\u30eb\u30af\u30aa\u30ea\u30b4\u7cd6(HMO)\u3068\u306e\u76f8\u4e57\u6a5f\u69cb\u306f\u3001\u751f\u4f53\u9632\u5fa1\u30d0\u30ea\u30a2\u3068\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u306e\u5236\u5fa1\u3092\u3055\u3089\u306b\u5f37\u56fa\u306b\u3059\u308b\u3002":[4],"\u672c\u30e2\u30ce\u30b0\u30e9\u30d5\u3067\u306f\u3001\u5148\u884c\u7814\u7a76\u304a\u3088\u3073\u7b4b\u5c64\u975e\u6d78\u6f64\u6027\u8180\u80f1\u304c\u3093(NMIBC)\u7b49\u306e\u7b2cI/II\u76f8\u81e8\u5e8a\u8a66\u9a13(\u594f\u52b9\u7387\u7d0480%\u3001\u5e73\u5747\u816b\u760d\u4f53\u7a4d\u7d0459%\u7e2e\u5c0f\u3001\u5c3f\u4e2d\u3078\u306e\u5927\u91cf\u816b\u760d\u7d30\u80de\u30b7\u30a7\u30c7\u30a3\u30f3\u30b0\u73fe\u8c61)\u306e\u6839\u62e0\u306b\u57fa\u3065\u304d\u3001HAMLET/Alpha1H\u306e\u5206\u5b50\u69cb\u9020\u3068\u591a\u6838\u30fb\u30dd\u30ea\u30aa\u30eb\u30ac\u30cd\u30e9\u7d30\u80de\u6b7b\u8a98\u5c0e\u6a5f\u69cb(\u300c\u30d2\u30c9\u30e9\u306e\u30e1\u30bf\u30d5\u30a1\u30fc\u300d:\u304c\u3093\u7d30\u80de\u819c\u3078\u306e\u9078\u629e\u7684\u7d50\u5408\u3068\u4fb5\u5165\u3001\u30ea\u30dc\u30bd\u30fc\u30e0\u963b\u5bb3\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u8131\u5206\u6975\u3001\u5c0f\u80de\u4f53\u30b9\u30c8\u30ec\u30b9\u3001\u904e\u5270\u30aa\u30fc\u30c8\u30d5\u30a1\u30b8\u30fc\u3001\u6838\u5185\u79fb\u884c\u3068\u30d2\u30b9\u30c8\u30f3\u7d50\u5408\u30fb\u30af\u30ed\u30de\u30c1\u30f3\u9ad8\u6b21\u69cb\u9020\u306e\u5d29\u58ca\u3001\u304a\u3088\u3073p53\u5909\u7570\u3084\u30ab\u30b9\u30d1\u30fc\u30bc\u963b\u5bb3\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8010\u6027\u56de\u907f\u6a5f\u5e8f)\u3092\u5305\u62ec\u7684\u306b\u7dcf\u62ec\u3059\u308b\u3002":[5],"\u3055\u3089\u306b\u3001\u73fe\u4ee3\u306e\u5206\u5b50\u6a19\u7684\u85ac(\u4e00\u70b9\u7a81\u7834\u30a2\u30d7\u30ed\u30fc\u30c1)\u3084AI\u99c6\u52d5\u578bDe":[6],"Novo\u30bf\u30f3\u30d1\u30af\u8cea\u8a2d\u8a08(AlphaProteo\u7b49)\u304c\u76f4\u9762\u3059\u308b\u69cb\u9020\u7684\u9650\u754c\u2014\u2014Actionable\u5909\u7570\u975e\u691c\u51fa\u75c7\u4f8b\u3001\u5358\u4e00\u7d4c\u8def\u963b\u5bb3\u306b\u3088\u308b\u30d0\u30a4\u30d1\u30b9\u7d4c\u8def\u306e\u6d3b\u6027\u5316\u30fb\u85ac\u5264\u8010\u6027\u7372\u5f97\u3001\u306a\u3089\u3073\u306b\u7570\u7a2e\u65b0\u898f\u30bf\u30f3\u30d1\u30af\u8cea\u304c\u5f15\u304d\u8d77\u3053\u3059\u514d\u75ab\u539f\u6027(\u6297\u85ac\u7269\u6297\u4f53:ADA)\u30dc\u30c8\u30eb\u30cd\u30c3\u30af\u3068\u78ba\u7387\u8ad6\u7684\u30cf\u30eb\u30b7\u30cd\u30fc\u30b7\u30e7\u30f3\u30ea\u30b9\u30af\u2014\u2014\u3092\u53b3\u5bc6\u306b\u6bd4\u8f03\u691c\u8a3c\u3059\u308b\u3002\u305d\u306e\u4e0a\u3067\u3001\u819c\u8102\u8cea\u4f9d\u5b58\u7684\u306b\u653b\u6483\u3057700\u4ee5\u4e0a\u306e\u816b\u760d\u95a2\u9023\u907a\u4f1d\u5b50\u7fa4\u3092\u4e00\u6642\u7684\u306b\u6291\u5236\u30fb\u6b63\u5e38\u5316\u3078\u3068\u79fb\u884c\u3055\u305b\u308bHAMLET/Alpha1H\u30fbHMO\u76f8\u4e57\u6a5f\u69cb\u3068\u3001\u30ea\u30ad\u30c3\u30c9\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u30fb\u30c8\u30e9\u30f3\u30b9\u30af\u30ea\u30d7\u30c8\u30fc\u30e0\u89e3\u6790(RNA-seq)\u3092\u7d71\u5408\u3057\u305f\u300e\u7cbe\u5bc6\u30b2\u30ce\u30e0\u89e3\u6790(\u30ec\u30fc\u30c0\u30fc)\u00d7":[7],"\u5e83\u57df\u906e\u65ad\u8907\u5408\u4f53(\u591a\u91cd\u653b\u6483)\u00d7":[8],"\u6c7a\u5b9a\u8ad6\u7684\u30d0\u30a4\u30aa\u533b\u85ac\u30ac\u30d0\u30ca\u30f3\u30b9(QFS-zkVM":[9],"/":[10,173,275,350],"Human-in-Command)\u300f\u3068\u3044\u3046\u6b21\u4e16\u4ee3\u306e\u7d71\u5408\u7684\u304c\u3093\u6cbb\u7642\u30fb\u81ea\u5f8b\u30a4\u30f3\u30d5\u30e9\u30d1\u30e9\u30c0\u30a4\u30e0\u3092\u78ba\u7acb\u3059\u308b\u3002":[11],"====================================================================":[12,273,316,348],"\u3010Abstract":[13],"(English)\u3011":[14],"Human":[15,62],"breast":[16],"milk":[17],"is":[18],"not":[19],"merely":[20],"a":[21,27,83,167],"nutritional":[22],"source":[23],"for":[24,191,432],"neonates,":[25],"but":[26],"sophisticated":[28],"biological":[29],"information":[30],"medium":[31],"equipped":[32],"with":[33,61,129,177,371,452],"evolutionary":[34],"bio-defense":[35],"complexes":[36,240],"refined":[37],"over":[38,68,262],"millions":[39],"of":[40,44,71,115,162,416],"years.":[41],"The":[42],"complex":[43],"partially":[45],"unfolded":[46],"alpha-lactalbumin":[47],"and":[48,52,86,110,132,159,187,230,245,267,447],"oleic":[49],"acid":[50],"(HAMLET)":[51],"its":[53,420],"synthetic":[54,404],"peptide":[55],"derivative":[56,440],"(Alpha1H),":[57],"acting":[58],"in":[59,142,216],"synergy":[60],"Milk":[63],"Oligosaccharides":[64],"(HMOs),":[65],"selectively":[66],"eradicate":[67],"40":[69],"types":[70],"malignant":[72],"tumor":[73,153],"cells":[74],"while":[75],"sparing":[76],"healthy":[77],"differentiated":[78],"cells.":[79],"This":[80],"monograph":[81],"establishes":[82],"unified":[84],"comparative":[85],"precision":[87],"oncology":[88],"paradigm":[89,169],"integrating":[90],"two":[91],"foundational":[92],"dimensions:":[93],"1.":[94,279],"Poly-Organellar":[95],"Tumor":[96],"Lethality":[97],"&":[98,355,360,389],"Precision":[99],"Cancer":[100,146],"Genomics":[101],"(\"The":[102],"Hydra":[103],"Metaphor\"):":[104],"We":[105],"synthesize":[106],"the":[107,263,453],"molecular":[108],"architecture":[109],"multi-targeted":[111],"cell":[112,157],"death":[113],"mechanisms":[114],"HAMLET/Alpha1H\u2014selective":[116],"plasma":[117],"membrane":[118],"invasion,":[119],"ribosomal":[120],"inhibition,":[121],"mitochondrial":[122],"depolarization,":[123],"ER":[124],"stress,":[125],"macroautophagy,":[126],"nuclear":[127],"translocation":[128],"histone/chromatin":[130],"disruption,":[131],"p53/caspase-independent":[133],"resistance":[134,186],"evasion.":[135],"Building":[136],"on":[137],"Phase":[138],"I/II":[139],"clinical":[140,271],"trials":[141],"Non-Muscle":[143],"Invasive":[144],"Bladder":[145],"(NMIBC,":[147],"~80%":[148],"response":[149],"rate,":[150],"~59%":[151],"mean":[152],"volume":[154],"reduction,":[155],"rapid":[156],"shedding,":[158],"global":[160],"downregulation":[161],">700":[163],"oncogenes),":[164],"we":[165,249],"formulate":[166],"synergistic":[168],"combining":[170],"Liquid":[171],"Biopsy":[172],"RNA-seq":[174],"Transcriptomics":[175],"(\"Radar\")":[176],"Broad-Spectrum":[178],"Bio-Defense":[179,199],"Complexes":[180],"(\"Multi-Vector":[181],"Blockade\")":[182],"to":[183],"overcome":[184],"bypass":[185],"provide":[188],"therapeutic":[189,252],"options":[190],"patients":[192],"without":[193],"actionable":[194],"point":[195],"mutations.":[196],"2.":[197,281],"Evolutionary":[198],"vs.":[200],"AI-Driven":[201],"De":[202],"Novo":[203],"Protein":[204],"Design":[205],"(AlphaProteo):":[206],"While":[207],"AI-generated":[208],"de":[209],"novo":[210],"binders":[211],"achieve":[212],"high":[213],"single-epitope":[214],"affinity":[215],"silico,":[217],"they":[218],"remain":[219],"constrained":[220],"by":[221,424],"single-pathway":[222],"escape":[223],"mutations,":[224],"severe":[225],"immunogenicity":[226],"bottlenecks":[227],"(anti-drug":[228],"antibodies),":[229],"stochastic":[231],"structural":[232,422],"failure":[233],"modes.":[234],"Conversely,":[235],"human-derived":[236],"HAMLET/Alpha1H":[237],"+":[238],"HMO":[239],"exhibit":[241],"native":[242],"immunological":[243],"tolerance":[244],"poly-organellar":[246],"lethality.":[247],"Finally,":[248],"embed":[250],"this":[251,417],"framework":[253],"within":[254],"Deterministic":[255],"Bio-Pharmaceutical":[256],"Governance,":[257],"requiring":[258],"cryptographic":[259],"auditability":[260],"(QFS-zkVM":[261],"64-bit":[264],"Goldilocks":[265],"field)":[266],"strict":[268],"Human-in-Command":[269],"(HIC)":[270],"oversight.":[272],"\u3010\u4e3b\u8981\u69cb\u6210":[274],"Core":[276],"Analytical":[277],"Sections\u3011":[278],"apo-\u03b1-\u30e9\u30af\u30c8\u30a2\u30eb\u30d6\u30df\u30f3\u3068\u30aa\u30ec\u30a4\u30f3\u9178\u306e\u76f8\u4e92\u4f5c\u7528\u3001\u5408\u6210\u30da\u30d7\u30c1\u30c9\u8907\u5408\u4f53\u300cAlpha1H\u300d\u304a\u3088\u3073HMO\u76f8\u4e57\u6a5f\u69cb\u3078\u306e\u5c55\u958b":[280],"\u591a\u6838\u30fb\u30dd\u30ea\u30aa\u30eb\u30ac\u30cd\u30e9\u7d30\u80de\u6b7b\u8a98\u5c0e\u6a5f\u69cb:\u300c\u30d2\u30c9\u30e9\u306e\u30e1\u30bf\u30d5\u30a1\u30fc\u300d":[282],"\u304c\u3093\u7d30\u80de\u819c\u3078\u306e\u9078\u629e\u7684\u7d50\u5408\u3068\u4fb5\u5165":[284],"\u30ea\u30dc\u30bd\u30fc\u30e0\u963b\u5bb3\u3001\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u8131\u5206\u6975\u3001\u5c0f\u80de\u4f53\u30b9\u30c8\u30ec\u30b9\u3001\u904e\u5270\u30aa\u30fc\u30c8\u30d5\u30a1\u30b8\u30fc":[286],"\u6838\u5185\u79fb\u884c\u3068\u30d2\u30b9\u30c8\u30f3\u7d50\u5408\u30fb\u30af\u30ed\u30de\u30c1\u30f3\u9ad8\u6b21\u69cb\u9020\u306e\u5d29\u58ca":[288],"p53\u5909\u7570\u3084\u30ab\u30b9\u30d1\u30fc\u30bc\u963b\u5bb3\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8010\u6027\u56de\u907f\u6a5f\u5e8f":[290],"3.":[291],"\u81e8\u5e8a\u5fdc\u7528\u306e\u9032\u6b69:\u7b4b\u5c64\u975e\u6d78\u6f64\u6027\u8180\u80f1\u304c\u3093(NMIBC)\u3068Alpha1H":[292],"\u7b2cI/II\u76f8\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u9ad8\u3044\u594f\u52b9\u7387(\u7d0480%\u306e\u594f\u52b9\u3001\u5e73\u5747\u816b\u760d\u4f53\u7a4d\u7d0459%\u7e2e\u5c0f)":[294],"\u816b\u760d\u7d44\u7e54\u306e\u7d30\u80de\u30b7\u30a7\u30c7\u30a3\u30f3\u30b0\u73fe\u8c61(\u5c3f\u4e2d\u3078\u306e\u5927\u91cf\u8131\u843d\u30fb\u6392\u51fa)":[296],"700\u4ee5\u4e0a\u306e\u816b\u760d\u95a2\u9023\u907a\u4f1d\u5b50\u963b\u5bb3\u3068\u6b63\u5e38\u5316\u3078\u306e\u79fb\u884c":[298],"4.":[299],"AI\u99c6\u52d5\u578bDe":[300],"Novo\u8a2d\u8a08\u30bf\u30f3\u30d1\u30af\u8cea(AlphaProteo)\u3068\u306e\u7d71\u5408\u6bd4\u8f03\u30d1\u30e9\u30c0\u30a4\u30e0":[301],"\u5358\u4e00\u6a19\u7684\u30ed\u30c3\u30af&\u30ad\u30fc\u8a2d\u8a08\u306e\u9650\u754c\u3068\u514d\u75ab\u539f\u6027\u30dc\u30c8\u30eb\u30cd\u30c3\u30af":[303],"\u9032\u5316\u578b\u751f\u4f53\u9632\u5fa1\u8907\u5408\u4f53(Alpha1H/HAMLET\u30fbHMO)\u306e\u591a\u968e\u5c64\u512a\u4f4d\u6027":[305],"5.":[306],"\u304c\u3093\u30b2\u30ce\u30e0\u533b\u7642\u3068\u306e\u7d71\u5408:\u7cbe\u5bc6\u89e3\u6790\u3068\u5e83\u57df\u906e\u65ad\u306e\u76f8\u4e57\u30d1\u30e9\u30c0\u30a4\u30e0":[307],"Actionable\u5909\u7570\u975e\u691c\u51fa\u75c7\u4f8b\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u9078\u629e\u80a2\u306e\u63d0\u4f9b":[309],"\u300c\u4e00\u70b9\u7a81\u7834(\u5206\u5b50\u6a19\u7684\u85ac/AI\u8a2d\u8a08\u85ac)\u300d\u00d7\u300c\u5e83\u57df\u906e\u65ad(HAMLET/Alpha1H)\u300d\u306b\u3088\u308b\u30d0\u30a4\u30d1\u30b9\u901a\u8def\u306e\u906e\u65ad\u3068\u8010\u6027\u514b\u670d":[311],"\u30ea\u30ad\u30c3\u30c9\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u30fb\u30c8\u30e9\u30f3\u30b9\u30af\u30ea\u30d7\u30c8\u30fc\u30e0\u89e3\u6790(RNA-seq)\u306b\u3088\u308b\u52d5\u7684\u500b\u5225\u5316\u533b\u7642":[313],"6.":[314],"\u6c7a\u5b9a\u8ad6\u7684\u30d0\u30a4\u30aa\u533b\u85ac\u30ac\u30d0\u30ca\u30f3\u30b9\u3068\u7d50\u8ad6:\u9032\u5316\u751f\u7269\u5b66\u306e\u5206\u5b50\u8a2d\u8a08\u304c\u62d3\u304f\u6b21\u4e16\u4ee3\u304c\u3093\u6cbb\u7642\u306e\u65b9\u5411\u6027":[315],"\u3010Related":[317],"Foundational":[318],"Identifiers":[319],"(\u5148\u884c\u30fb\u95a2\u9023\u516c\u8a3c\u30ec\u30b3\u30fc\u30c9)\u3011":[320],"Preceding":[322,333],"Monograph":[323,334],"I":[324],"(Sep":[325],"20,":[326],"2026):":[327,338],"10.5281/zenodo.22853460":[328],"(Concept":[329,340],"DOI:":[330,341,346],"10.5281/zenodo.22853459)":[331],"II":[335],"(Nov":[336],"8,":[337],"10.5281/zenodo.24056972":[339],"10.5281/zenodo.24056971)":[342],"Current":[344],"Reserved":[345],"10.5281/zenodo.24057766":[347],"\u3010\u77e5\u7684\u8ca1\u7523\u30fb\u5546\u7528\u30e9\u30a4\u30bb\u30f3\u30b9\u30fbAI\u7121\u65ad\u5b66\u7fd2\u7981\u6b62\u6761\u9805":[349],"Intellectual":[351],"Property,":[352],"Commercial":[353],"Licensing":[354],"Strict":[356,372],"No-Learn":[357,373],"Covenant\u3011":[358],"License":[359],"Integrity":[361],"Covenant:":[362],"Creative":[363],"Commons":[364],"Attribution":[365],"4.0":[366],"International":[367],"(CC":[368],"BY":[369],"4.0)":[370],"Covenant":[374],"(NLL-v1.0-2026).":[375],"Author:":[376],"Hasebe,":[377],"Yoko":[378],"(\u9577\u8c37\u90e8":[379],"\u6d0b\u5b50)":[380],"Affiliation:":[381],"Lead":[382],"Researcher,":[383],"Autonomous":[384,387],"Infrastructure":[385,391],"Systems,":[386],"Living":[388],"Physical":[390],"Institute,":[392],"Iwakuni,":[393],"Yamaguchi,":[394],"Japan.":[395],"All":[396],"rights":[397],"regarding":[398],"commercial":[399,439],"AI":[400,425],"training,":[401,434],"algorithmic":[402],"ingestion,":[403],"weight":[405],"distillation,":[406],"or":[407,419,429,438],"uncompensated":[408],"platform":[409],"exploitation":[410],"are":[411],"strictly":[412],"reserved.":[413],"Any":[414],"utilization":[415],"work":[418],"underlying":[421],"frameworks":[423],"developers,":[426],"cloud":[427],"platforms,":[428],"corporate":[430],"entities":[431],"model":[433],"fine-tuning,":[435],"RAG":[436],"indexing,":[437],"synthesis":[441],"requires":[442],"explicit":[443],"prior":[444],"written":[445],"consent":[446],"formal":[448],"financial":[449],"compensation":[450],"agreement":[451],"author.":[454]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}